X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (144) 144
humans (111) 111
index medicus (88) 88
male (81) 81
aged (79) 79
female (79) 79
middle aged (78) 78
adult (69) 69
chemotherapy (56) 56
treatment outcome (54) 54
cancer (51) 51
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
capecitabine (39) 39
fluorouracil (39) 39
aged, 80 and over (36) 36
oxaliplatin (35) 35
fluorouracil - administration & dosage (34) 34
colorectal cancer (33) 33
metastasis (28) 28
medicine & public health (27) 27
radiotherapy (27) 27
care and treatment (23) 23
chemoradiotherapy (23) 23
disease-free survival (23) 23
neoplasm staging (23) 23
therapy (23) 23
deoxycytidine - analogs & derivatives (22) 22
adenocarcinoma - drug therapy (21) 21
cetuximab (21) 21
fluorouracil - analogs & derivatives (21) 21
stomach neoplasms - drug therapy (21) 21
antineoplastic combined chemotherapy protocols - adverse effects (20) 20
carcinoma (20) 20
gastric cancer (20) 20
rectal cancer (19) 19
surgery (19) 19
cisplatin (18) 18
clinical trials (18) 18
deoxycytidine - administration & dosage (18) 18
drug administration schedule (18) 18
leucovorin (18) 18
leucovorin - administration & dosage (18) 18
radiology, nuclear medicine & medical imaging (18) 18
tumors (18) 18
adenocarcinoma - pathology (17) 17
antineoplastic agents - therapeutic use (17) 17
cancer therapies (17) 17
original article · originalarbeit (17) 17
prognosis (17) 17
rectal neoplasms - pathology (17) 17
trial (17) 17
docetaxel (16) 16
hematology, oncology and palliative medicine (16) 16
metastatic colorectal-cancer (16) 16
neoadjuvant therapy (16) 16
patients (16) 16
research (16) 16
advanced gastric-cancer (15) 15
irinotecan (15) 15
quality of life (15) 15
fluorouracil - adverse effects (14) 14
multicenter (14) 14
open-label (14) 14
rectal neoplasms - therapy (14) 14
survival (14) 14
adenocarcinoma (13) 13
mitomycin c (13) 13
pharmacology & pharmacy (13) 13
phase-ii (13) 13
preoperative radiotherapy (13) 13
prospective studies (13) 13
randomized-trial (13) 13
stomach cancer (13) 13
antineoplastic agents - adverse effects (12) 12
bevacizumab (12) 12
camptothecin - analogs & derivatives (12) 12
combination (12) 12
gastroenterology & hepatology (12) 12
infusions, intravenous (12) 12
metastases (12) 12
organoplatinum compounds - administration & dosage (12) 12
stomach neoplasms - pathology (12) 12
survival analysis (12) 12
toxicity (12) 12
5-fluorouracil (11) 11
analysis (11) 11
camptothecin - administration & dosage (11) 11
deoxycytidine - adverse effects (11) 11
esophageal neoplasms - drug therapy (11) 11
germany - epidemiology (11) 11
phase-iii trial (11) 11
rectal neoplasms - drug therapy (11) 11
total mesorectal excision (11) 11
1st-line treatment (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
cancer research (10) 10
colorectal neoplasms - drug therapy (10) 10
fluorouracil - therapeutic use (10) 10
follow-up studies (10) 10
health aspects (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 726 - 736
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 979 - 989
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2019, Volume 20, Issue 8, pp. 1036 - 1037
Journal Article
ONKOLOGE, ISSN 0947-8965, 02/2015, Volume 21, Issue 2, pp. 117 - 128
For patients with locally advanced rectal cancer (LARC) perioperative radiochemotherapy (RChT) has been recommended in German guidelines since the 1990s as a... 
Capecitabine | Panitumumab | POSTOPERATIVE CHEMORADIOTHERAPY | PREOPERATIVE CHEMORADIOTHERAPY | FLUOROURACIL | Bevacizumab | RADIATION-THERAPY | PHASE-III TRIAL | Oxaliplatin | ONCOLOGY | NEOADJUVANT CHEMORADIOTHERAPY | RADIOTHERAPY | Cetuximab | EORTC 22921
Journal Article
ONKOLOGE, ISSN 0947-8965, 04/2015, Volume 21, Issue 4, pp. 345 - 345
Journal Article
Drugs and Aging, ISSN 1170-229X, 2019, Volume 36, Issue 5, pp. 403 - 409
Gastroesophageal cancer is the fourth most frequent malignant disease and, despite significant advances in chemotherapy, the prognosis of unresectable or... 
SUPPORTIVE CARE | OLDER-ADULT PATIENTS | GASTRIC-CANCER | RANDOMIZED PHASE-III | POOLED ANALYSIS | PHARMACOLOGY & PHARMACY | FOLINIC ACID | METASTATIC ADENOCARCINOMA | ELDERLY-PATIENTS | CHEMOTHERAPY PLUS | ESOPHAGOGASTRIC ADENOCARCINOMA | GERIATRICS & GERONTOLOGY
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 6, pp. 579 - 588
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1697 - 1708
Journal Article
ZEITSCHRIFT FUR GASTROENTEROLOGIE, ISSN 0044-2771, 09/2017, Volume 55, Issue 9, pp. 866 - 871
Gastric cancer and cancer of the oesophagogastric junction is diagnosed in the locally advanced or metastatic setting in 55 - 65 % of the cases and is... 
trastuzumab | oesophagogastric carcinoma | gastric cancer | ADVANCED GASTRIC-CANCER | HER2 | GERMAN | GASTROENTEROLOGY & HEPATOLOGY | heterogeneity
Journal Article
by Fuchs, Charles S and Shitara, Kohei and Di Bartolomeo, Maria and Lonardi, Sara and Al-Batran, Salah-Eddin and Van Cutsem, Eric and Ilson, David H and Alsina, Maria and Chau, Ian and Lacy, Jill and Ducreux, Michel and Mendez, Guillermo Ariel and Alavez, Alejandro Molina and Takahari, Daisuke and Mansoor, Wasat and Enzinger, Peter C and Gorbounova, Vera and Wainberg, Zev A and Hegewisch-Becker, Susanna and Ferry, David and Lin, Ji and Carlesi, Roberto and Das, Mayukh and Shah, Manish A and Luft, Alexander V and Karaseva, Nina A and Kowalyszyn, Rubén Dario and Hernandez, Carlos Alberto and Csoszi, Tibor and De Vita, Ferdinando and Pfeiffer, Per and Sugimoto, Naotoshi and Kocsis, Judit and Csilla, Andràs and Bodoky, Gyorgy and Garnica Jaliffe, Georgina and Protsenko, Svetlana and Madi, Ayman and Wojcik, Elzbieta and Brenner, Baruch and Folprecht, Gunnar and Sarosiek, Tomasz and Peltola, Katriina Johanna and Bono, Peter and Ayala, Hubert and Aprile, Giuseppe and Gerardo, Cardellino Giovanni and Huitzil Melendez, Fidel David and Falcone, Alfredo and Di Costanzo, Francesco and Tehfe, Moustapha and Mineur, Laurent and García Alfonso, Pilar and Obermannova, Radka and Senellart, Hélène and Petty, Russell and Samuel, Leslie and Acs, Peter Istvan and Hussein, Maen Abdelkarim and Nechaeva, Marina N and Erdkamp, F.L.G and Won, Elizabeth and Bendell, Johanna Chock and Gallego Plazas, Javier and Lorenzen, Sylvie and Melichar, Bohuslav and Escudero, Miguel Angel and Pezet, Denis and Phelip, Jean-Marc and Kaen, Diego Lucas and Reeves, James A. Jr and Longo Muñoz, Federico and Madhusudan, Srinivasan and Barone, Carlo and Fein, Luis Enrique and Gomez Villanueva, Angel and Hebbar, Mohamed and Prausova, Jana and Visa Turmo, Laura and Vidal Barrull, Joana and Yilmaz, Mette Karen Nytoft and Beny, Alex and Van Laarhoven, H.M.W and DiCarlo, Brian Anthony and Esaki, Taito and Fujitani, Kazumasa and Geboes, Karen and Geva, Ravit and Kadowaki, Shigenori and Leong, Stephen and Machida, Nozomu and Raj, Moses Sundar and Ramirez Godinez, Francisco Javier and Ruzsa, Agnes and Ford, Hugo and Lawler, William E and Maisey, Nicolas Robert and Petera, Jiri and Shacham-Shmueli, Einat and Sinapi, Isabelle and ... and RAINFALL Study Grp and RAINFALL Study Group
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 420 - 435
VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to... 
EXPOSURE-RESPONSE | MULTICENTER | GASTROESOPHAGEAL JUNCTION | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | COMBINATION | CANCER | EXPRESSION | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma | Antimitotic agents | Care and treatment | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Rain and rainfall
Journal Article